A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. - Wikidata - awgldk - TriplyDB

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

http://www.wikidata.org/entity/Q33358562

about

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelines Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions Managing Antiplatelet Therapy and Anticoagulants in Patients with Coronary Artery Disease and Atrial Fibrillation The role of antiplatelet therapy in the management of acute coronary syndromes Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction Medications for the treatment of acute coronary syndromes Clopidogrel in acute coronary heart disease Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention Role of abciximab in the treatment of coronary artery disease Debate of adjunctive pharmacology for percutaneous coronary intervention: anticoagulation and clopidogrel are not (always) enough The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and design Oral antiplatelet therapy and percutaneous coronary intervention Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapy Clopidogrel in the treatment of ischaemic heart disease Contemporary issues in clopidogrel therapy: new evidence shaping clinical practice Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome.Percutaneous coronary intervention: recommendations for good practice and training.The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio.CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention.The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis.Risk of thrombocytopenia with glycoprotein IIb/IIIa inhibitors across drugs and patient populations: a meta-analysis of 29 large placebo-controlled randomized trials.Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry.Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics.Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis.The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients at High Risk for Bleeding Coronary revascularization in diabetic patients: Current state of evidence.What is the incidence of myocardial necrosis in elective patients discharged on the same day following percutaneous coronary intervention?Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

P2860

Q22242057-EA81D3CC-0DEE-48E1-BA80-AD8D1327014A Q24202522-2D4A201D-A842-487A-9BEF-051C23AD410A Q24202999-A9F809E2-B028-4835-A796-AAEBEAC9E8C7 Q24235385-99F1E242-4228-42FC-91DD-67E8E0451653 Q24653318-66D00301-FD2F-4C50-8398-8D08B1D15F08 Q26740181-21693AD4-4000-42CE-8412-10FF60428ADE Q28080247-2BDD5830-27D4-4A24-B762-C0775E7C4773 Q28176548-882EED4A-7E0C-4764-AF0B-EF3A6A73532D Q28191096-69B88BE4-D298-4F9D-90E3-201E06C3FD65 Q28193674-CA332820-D433-4C66-A210-97D710B388A1 Q28193776-5E1BE2DE-3C8B-48AB-A30F-5E2D28CB4F4C Q28199725-2BC2ADC3-29F8-408C-A857-C8B2D3425AED Q28199817-D65D0D00-089A-416E-9C02-BFBB17536907 Q28200177-468A5B94-1AE1-4A7A-8B6F-576BD9F2538D Q28200611-833F506D-4F9B-46D0-870B-3FD5F47AEC06 Q28200757-BC99B633-053A-4390-8AD3-BD32065079D5 Q28210631-5A25920F-2204-4B05-BE21-B72ABF3CE21B Q28217724-F558BDB9-FD87-4737-8697-9646D7D0550C Q28218066-D9D94563-B762-45F2-A833-1EE85D5C15F4 Q28218576-87EF9CE2-A105-48F5-AD82-DF8BF8332FFB Q28221366-16C51E41-C093-4F40-83CE-0B83D6616E9E Q28239975-EF29C2EC-2E08-4B97-ABFA-72A30EE0B328 Q30402038-CBEBA1E4-623F-49BF-A4C6-6B341DDDABC3 Q30479477-1726D1E1-E826-41E4-88BE-BF20AD69CDBC Q31150630-B329747F-39B1-47C5-908D-D4EB71D92821 Q33238884-A3D68CA3-4E32-4BFC-AB9C-C1B5B1C68F9C Q33368192-2E1E7FC6-5D2D-4B8D-B4DB-E452264827B4 Q33376977-71FDAA77-27AC-49DE-839B-7AFBCF2FF42B Q33387192-F23B8D8A-74F6-401D-A576-B19D60BF5633 Q33390176-B8E32A01-5325-4847-9A98-10D2A151FBDE Q33434702-C76F4A02-AF11-411D-B8F5-D728E2927738 Q33865395-DA154AE5-1957-4283-B1D5-024CEEFAEF70 Q33876187-684C2DBB-936D-466C-84FB-9B67C89C29BA Q33934090-FDF96214-9ACA-4CF4-9F2A-AF40A922F27A Q34175429-2618694B-7883-4F6E-8286-863E613AFCB3 Q34572417-D2268FBB-6EED-49F9-9577-75E169FE380B Q34789840-FDDEDF8A-A033-4D24-96CD-916D8413DEFA Q35583201-138F337D-1C74-4BD8-B8F4-BD1647C67EEB Q35584682-8479FE0A-3336-44C9-82B6-9E5B5FAEB0B0 Q35752619-6C1AE24C-4758-4610-9D97-8E30277DD328

P2860

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

http://www.wikidata.org/entity/Q33358562

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

A clinical trial of abciximab ...... pretreatment with clopidogrel.

@ast

A clinical trial of abciximab ...... pretreatment with clopidogrel.

@en

type

label

A clinical trial of abciximab ...... pretreatment with clopidogrel.

@ast

A clinical trial of abciximab ...... pretreatment with clopidogrel.

@en

prefLabel

A clinical trial of abciximab ...... pretreatment with clopidogrel.

@ast

A clinical trial of abciximab ...... pretreatment with clopidogrel.

@en

P1433

Q33358562-F7C2C624-214E-46A4-B20C-B973FA4033A8

P1476

Q33358562-6C9FB802-CF7C-4B82-BAC5-C9E33EDE077D

P2093

Q33358562-33125D3A-D855-4956-9578-31E31F47F459

Q33358562-39B4E0A0-4B48-4415-94B1-A16FC57DFC18

Q33358562-6F7958AE-6B70-4171-B729-F5A67E471BE4

Q33358562-72A3A237-0C2B-4B07-A159-D0480E70422F

Q33358562-99976A91-9C00-459A-9D21-0C0866D80957

Q33358562-9FAF152C-E5C7-4735-B02B-E22FD15060F9

Q33358562-BE5FE5BC-A727-4E09-8503-561FFC869A7D

Q33358562-C5447C50-39AC-407A-AC37-5FF293DBC201

Q33358562-E092B7A2-9032-4A74-A00A-D80054791A40

Q33358562-E8B53372-BCFE-4BE6-A20F-B0164904804F

P304

Q33358562-E5C2F779-59C3-4B75-B9FF-6685459E2766

P31

Q33358562-DB0D0C80-1F7D-4F06-9924-5C47DE0BF146

P356

Q33358562-91050922-F951-4330-AFE7-DD28F9DE19BD

P407

Q33358562-F3A6C000-2F46-4B06-BE8D-76BC7BAB2169

P433

Q33358562-7CF84E6A-E575-4D3A-9B21-6ADEC07D5A54

P478

Q33358562-E875EACB-8F4C-450F-866D-FA7402D1EF77

P50

Q33358562-954DEF40-610F-4CAC-B0DB-AEB02D4B1D76

Q33358562-B6E014D7-E664-4075-91AA-73EAC34A1758

Q33358562-CE878726-A5A0-49A4-8B68-0445AAC3794D

P577

Q33358562-2AFE2667-9052-4AC2-B9E5-BD9C087220DF

P698

Q33358562-21C83A09-21EC-4B4D-8D69-E5E23A14EB8C

P921

Q33358562-A02A9203-EA74-4A7C-B1CB-B3F6544EB347

P356

P1433

The New England Journal of Medicine

P1476

A clinical trial of abciximab ...... pretreatment with clopidogrel.

@en

P2093

Christian Volmer

http://www.w3.org/2001/XMLSchema#string

Franz Dotzer

http://www.w3.org/2001/XMLSchema#string

Franz-Josef Neumann

http://www.w3.org/2001/XMLSchema#string

Helmut Schühlen

http://www.w3.org/2001/XMLSchema#string

Hildegard Bollwein

http://www.w3.org/2001/XMLSchema#string

Intracoronary Stenting and Ant ...... Treatment Study Investigators

http://www.w3.org/2001/XMLSchema#string

Josef Dirschinger

http://www.w3.org/2001/XMLSchema#string

Jurriën M ten Berg

http://www.w3.org/2001/XMLSchema#string

Meinrad Gawaz

http://www.w3.org/2001/XMLSchema#string

Peter B Berger

http://www.w3.org/2001/XMLSchema#string

P304

232-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA031859

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P50

Julinda Mehilli

Albert Schömig

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14724302

http://www.w3.org/2001/XMLSchema#string

P921